Want to see ICCM full AI Analyst Report?
Icecure Medical (ICCM) Stock Statistics & Valuation Metrics
Total Valuation
Icecure Medical has a market cap or net worth of $2.98M. The enterprise value is $4.71M.
- Market Cap
- $2.98M
- Enterprise Value
- $4.71M
Share Statistics
Icecure Medical has 3,426,715 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,426,715
- Owned by Insiders
- 19.28%
- Owned by Institutions
- 0.58%
Financial Efficiency
Icecure Medical’s return on equity (ROE) is -1.66 and return on invested capital (ROIC) is -162.86%.
- Return on Equity (ROE)
- -1.66
- Return on Assets (ROA)
- -1.08
- Return on Invested Capital (ROIC)
- -162.86%
- Return on Capital Employed (ROCE)
- -1.67
- Revenue Per Employee
- 49.69K
- Profits Per Employee
- -221.43K
- Employee Count
- 68
- Asset Turnover
- 0.24
- Inventory Turnover
- 0.82
Valuation Ratios
The current PE Ratio of Icecure Medical is -0.13. Icecure Medical’s PEG ratio is -0.01.
- PE Ratio
- -0.13
- PS Ratio
- 0.50
- PB Ratio
- 0.23
- Price to FCF
- -0.12
- Price to Operating Cash Flow
- -0.16
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Icecure Medical had revenue of 3.38M and earned -15.06M in profits. Earnings per share was -7.10.
- Revenue
- 3.38M
- Gross Profit
- 1.23M
- Operating Income
- -15.09M
- Pretax Income
- -15.06M
- Net Income
- -15.06M
- EBITDA
- -14.80M
- Earnings Per Share (EPS)
- -7.10
Cash Flow
In the last 12 months, operating cash flow was -16.32M and capital expenditures -69,771, giving a free cash flow of -16.39M billion.
- Operating Cash Flow
- -16.32M
- Free Cash Flow
- -16.39M
- Free Cash Flow per Share
- -5.31
Dividends & Yields
Icecure Medical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -836.39%
- Earnings Yield
- -628.50%
Stock Price Statistics
- Beta
- 0.33
- 52-Week Price Change
- -95.92%
- 50-Day Moving Average
- 1.65
- 200-Day Moving Average
- 7.63
- Relative Strength Index (RSI)
- 18.15
- Average Volume (3m)
- 145.84K
Important Dates
Icecure Medical upcoming earnings date is Nov 25, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 12, 2026
- Next Earnings Date
- Nov 25, 2026
- Ex-Dividend Date
- ―
Financial Position
Icecure Medical as a current ratio of 2.61, with Debt / Equity ratio of 2.40%
- Current Ratio
- 2.61
- Quick Ratio
- 2.07
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.59
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Icecure Medical has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Icecure Medical EV to EBITDA ratio is 0.61, with an EV/FCF ratio of 0.61.
- EV to Sales
- -2.53
- EV to EBITDA
- 0.61
- EV to Free Cash Flow
- 0.61
- EV to Operating Cash Flow
- 0.61
Balance Sheet
Icecure Medical has $12.03M in cash and marketable securities with $90.00K in debt, giving a net cash position of $11.94M billion.
- Cash & Marketable Securities
- $12.03M
- Total Debt
- $90.00K
- Net Cash
- $11.94M
- Net Cash Per Share
- $3.49
- Tangible Book Value Per Share
- $3.85
Margins
Gross margin is 36.10%, with operating margin of -556.35%, and net profit margin of -427.67%.
- Gross Margin
- 36.10%
- Operating Margin
- -556.35%
- Pretax Margin
- -427.67%
- Net Profit Margin
- -427.67%
- EBITDA Margin
- -416.49%
- EBIT Margin
- -423.69%
Analyst Forecast
The average price target for Icecure Medical is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $10.00
- Price Target Upside
- 1049.43% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- 41.62%
- EPS Growth Forecast
- 20.47%
Scores
- Smart Score
- ―
- AI Score
- 46
